UBE2S and prostate carcinoma: The most recent investigation has established that UBE2S, an E2 ubiquitin-conjugating enzyme, plays a critical role in stabilizing β-linked proteins via K16-linked ubiquitination, which is known to trigger enhanced migration and invasion of tumor cells in the context of prostate cancer bone metastases and promote oncogenic activities.